Ascendis Pharma
ASND
ASND
35 hedge funds and large institutions have $585M invested in Ascendis Pharma in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.75% less ownership
Funds ownership: 65.21% → 64.46% (-0.75%)
17% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 12
Holders
35
Holding in Top 10
7
Calls
–
Puts
–
Top Buyers
| 1 | +$9.19M | |
| 2 | +$8.33M | |
| 3 | +$4.36M | |
| 4 |
VMI
VHCP Management II
New York
|
+$2.53M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.41M |
Top Sellers
| 1 | -$3.38M | |
| 2 | -$2.48M | |
| 3 | -$2.24M | |
| 4 |
NC
Nexthera Capital
New York
|
-$2.02M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.99M |